EQ Health Acquisition Corp.
EQHAW
Other OTC0.03
USD
-NaN
- -
EQ Health Acquisition Corp.
EQHAW
(Other OTC)
Recent
price
0.03
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- EQ Health Acquisition Corp. (EQHAW) operates as a blank check company whose principal business activity focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting undervalued, growth-oriented companies in the healthcare services sector with enterprise values generally between $600 million and $1.25 billion; specific focus areas include alternative-site providers and services, home care and hospice, payor services, behavioral health, dental, physical therapy, and veterinary services. The company, founded in 2020 and headquartered at 4611 Bee Cave Road, Suite 213, Austin, Texas 78746, generates no revenues or significant operations prior to completing an initial business combination and maintains a lean structure with zero employees. Led by Executive Chairman Lewis Little Jr., a veteran healthcare operator with prior CEO roles at Covenant Physician Partners and Harden Healthcare where he executed over $300 million in acquisitions and expanded operations across multiple states; CEO, President, and CFO Scott Ellyson, founder of Clarity Performance Partners with over 25 years in healthcare and technology; and COO Benjamin Hanson, founder of EQ Capital Strategies with experience in post-acute care acquisitions, the management team leverages deep expertise in healthcare M&A, operations, and value creation, supported by co-sponsor FS Investments providing financial and research capabilities. In February 2021, EQ Health completed an upsized $220 million initial public offering of 22 million units at $10 each on the NYSE, including the full exercise of underwriter over-allotment, with Jefferies LLC and BTIG, LLC as joint book-runners, raising proceeds held in trust for a business combination that remains pending as of late 2025 with no announced target, merger, acquisition, or liquidation despite the passage of standard SPAC timelines. The company's common shares (EQHA), units (EQHAU), and warrants (EQHAW) continue to trade actively, reflecting ongoing market interest in potential de-SPAC activity amid a resurgent SPAC environment, though it holds approximately $276.65 million in market capitalization with reported TTM earnings of $9.67 million from warrant-related fair value changes rather than operational income.